ERBB2 and breast cancer: In this study, we sought to define the molecular and functional changes driving loss of HER2/neu expression and metastatic potential by examining a spontaneously derived metastatic breast cancer cell line, TUBO-P2J, with the parental HER2/neu positive cell line, TUBO.